
Baxter BioPharma Solutions
Advertisement
Articles by Baxter BioPharma Solutions


Your oncology product can make a difference in patients’ lives, and our oncology manufacturing expertise can help you make that difference.


Sponsored Content
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

Sponsored Content
This case study looks at considerations for formulations of Mannitol, a versatile excipient used in freeze-dried injectables in the pharmaceutical industry.
Advertisement
Latest Updated Articles
Complex Sterile Manufacturing of Oncology ProductsOctober 20th 2020
Hemihydrate Formation: Considerations for Mannitol FormulationsFebruary 24th 2020
Oncology Product Manufacturing in a Non-Dedicated FacilityMarch 19th 2020
Oncology Product Manufacturing in a Nondedicated FacilityMarch 19th 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
5